BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31599112)

  • 1. Modifications of H3K4 methylation levels are associated with DNA hypermethylation in acute myeloid leukemia.
    Scalea S; Maresca C; Catalanotto C; Marino R; Cogoni C; Reale A; Zampieri M; Zardo G
    FEBS J; 2020 Mar; 287(6):1155-1175. PubMed ID: 31599112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
    Paul TA; Bies J; Small D; Wolff L
    Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct ChIP-bisulfite sequencing reveals a role of H3K27me3 mediating aberrant hypermethylation of promoter CpG islands in cancer cells.
    Gao F; Ji G; Gao Z; Han X; Ye M; Yuan Z; Luo H; Huang X; Natarajan K; Wang J; Yang H; Zhang X
    Genomics; 2014; 103(2-3):204-10. PubMed ID: 24407023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
    Court F; Arnaud P
    Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenome of AML stem and progenitor cells.
    Yamazaki J; Estecio MR; Lu Y; Long H; Malouf GG; Graber D; Huo Y; Ramagli L; Liang S; Kornblau SM; Jelinek J; Issa JP
    Epigenetics; 2013 Jan; 8(1):92-104. PubMed ID: 23249680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients.
    Dodge JE; Munson C; List AF
    Leuk Res; 2001 Oct; 25(10):917-25. PubMed ID: 11532526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
    Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
    PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
    Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
    Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin states of developmentally-regulated genes revealed by DNA and histone methylation patterns in zebrafish embryos.
    Lindeman LC; Winata CL; Aanes H; Mathavan S; Alestrom P; Collas P
    Int J Dev Biol; 2010; 54(5):803-13. PubMed ID: 20336603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns.
    Skvortsova K; Masle-Farquhar E; Luu PL; Song JZ; Qu W; Zotenko E; Gould CM; Du Q; Peters TJ; Colino-Sanguino Y; Pidsley R; Nair SS; Khoury A; Smith GC; Miosge LA; Reed JH; Kench JG; Rubin MA; Horvath L; Bogdanovic O; Lim SM; Polo JM; Goodnow CC; Stirzaker C; Clark SJ
    Cancer Cell; 2019 Feb; 35(2):297-314.e8. PubMed ID: 30753827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low HOX gene expression in PML-RARα-positive leukemia results from suppressed histone demethylation.
    Rejlova K; Musilova A; Kramarzova KS; Zaliova M; Fiser K; Alberich-Jorda M; Trka J; Starkova J
    Epigenetics; 2018; 13(1):73-84. PubMed ID: 29224413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk.
    Brinkman AB; Gu H; Bartels SJ; Zhang Y; Matarese F; Simmer F; Marks H; Bock C; Gnirke A; Meissner A; Stunnenberg HG
    Genome Res; 2012 Jun; 22(6):1128-38. PubMed ID: 22466170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia.
    Dodge JE; List AF; Futscher BW
    Int J Cancer; 1998 Nov; 78(5):561-7. PubMed ID: 9808523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.
    Zhou JD; Zhang TJ; Wang YX; Yang DQ; Yang L; Ma JC; Wen XM; Yang J; Lin J; Qian J
    Tumour Biol; 2016 Jul; 37(7):8951-60. PubMed ID: 26753961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pilot Study of Aberrant CpG Island Hypermethylation of
    Sun J; Zhang J; Wang Y; Li Y; Zhang R
    Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.